Full Text View
Tabular View
No Study Results Posted
Related Studies
FK506 Phase 3 Study: a Study for Steroid Non-Resistant Myasthenia Gravis (MG) Patients
This study has been completed.
Study NCT00309088   Information provided by Astellas Pharma Inc

First Received on March 29, 2006.   Last Updated on July 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myasthenia Gravis
Additional conditions recognized in this trial
Muscle Weakness
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Immune System Diseases
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Neuromuscular Junction Diseases
Neuromuscular Manifestations
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
tacrolimus
placebo
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services